Artwork

Content provided by Trevor Shewfelt and Kirk Nyquist, Trevor Shewfelt, and Kirk Nyquist. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Trevor Shewfelt and Kirk Nyquist, Trevor Shewfelt, and Kirk Nyquist or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

E108 - Terry O'Regan and Brains Bioceutical (Re-Hash)

44:08
 
Share
 

Manage episode 400755701 series 2081912
Content provided by Trevor Shewfelt and Kirk Nyquist, Trevor Shewfelt, and Kirk Nyquist. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Trevor Shewfelt and Kirk Nyquist, Trevor Shewfelt, and Kirk Nyquist or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Terry O'Regan has spent his career in the pharmaceutical industry. He has worked for several Big Pharma companies including ones that have developed important treatments for neurological diseases like Multiple Sclerosis.

Terry had heard there was a class of therapeutics for neurological conditions that pharmaceutical companies weren't working on, cannabinoids. Terry kept hearing from neurologists that cannabinoids held great promise for neurological conditions.

Enter Brains Bioceutical. Brains is involved in trials around the world looking at phytochemicals including cannabinoids. Trevor and Terry discuss how cannabis medicine is moving into the pharmaceutical space and how all our "Brains" could be better with the right cannabinoids. Come have a listen.

Brains Bioceutical - brainsbioceutical.com

Terry O'Regan - LinkedIn

Music by:

The Sean Taylor Band - YouTube

Additional Music:

Desiree Dorion desireedorion.com

Marc Clement - Facebook

Transcripts, papers and so much more at: reefermed.ca

  continue reading

150 episodes

Artwork
iconShare
 
Manage episode 400755701 series 2081912
Content provided by Trevor Shewfelt and Kirk Nyquist, Trevor Shewfelt, and Kirk Nyquist. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Trevor Shewfelt and Kirk Nyquist, Trevor Shewfelt, and Kirk Nyquist or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Terry O'Regan has spent his career in the pharmaceutical industry. He has worked for several Big Pharma companies including ones that have developed important treatments for neurological diseases like Multiple Sclerosis.

Terry had heard there was a class of therapeutics for neurological conditions that pharmaceutical companies weren't working on, cannabinoids. Terry kept hearing from neurologists that cannabinoids held great promise for neurological conditions.

Enter Brains Bioceutical. Brains is involved in trials around the world looking at phytochemicals including cannabinoids. Trevor and Terry discuss how cannabis medicine is moving into the pharmaceutical space and how all our "Brains" could be better with the right cannabinoids. Come have a listen.

Brains Bioceutical - brainsbioceutical.com

Terry O'Regan - LinkedIn

Music by:

The Sean Taylor Band - YouTube

Additional Music:

Desiree Dorion desireedorion.com

Marc Clement - Facebook

Transcripts, papers and so much more at: reefermed.ca

  continue reading

150 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide